Legal-Bay Lawsuit Funding Announces Johnson & Johnson to stop U.S. Sales of Generational Baby Powder Product

Presettlement funding firm reports that the baby powder manufacturer could be looking to wrap up thousands of outstanding talcum powder cancer lawsuits.

News provided by

Legal-Bay LLC

May 20, 2020, 12:24 ET

NEW BRUNSWICK, N.J., May 20, 2020 /PRNewswire/ -- Legal-Bay LLC, the Lawsuit Settlement Funding Company, reports that Johnson & Johnson has finally removed their talcum-based baby powder from their sales line. The flagship product has been the target of numerous lawsuits in recent years, with claimants alleging that the product is directly responsible for their ovarian cancer.

While Johnson & Johnson has denied such accusations, the company has long been aware of the research tying a health risk to their talcum-based baby powder. Several studies dating back to the 1970s have concluded that talc particles increase a woman's risk of ovarian cancer, and evidence suggests that J&J has been intentionally concealing the results for decades.

In February, a New Jersey jury awarded $750 million in damages to four plaintiffs. The judge later reduced the payout to $186MM, but J&J still has over 18,000 lawsuits yet to face. The litigation could be expected to cost the manufacturing giant as much as $10 billion.

Chris Janish, CEO of Legal-Bay, commented, "We have been actively monitoring this landmark case for over five years, and we're happy to see Johnson & Johnson has finally taken the big step to remove this product from U.S. shelves. This announcement looks to be the start of some long-awaited vindication for the many women who've suffered ovarian cancer at the hands of their baby powder brand."

If you require an immediate cash advance from your anticipated Johnson & Johnson settlement, please visit the company's website HERE or call 877.571.0405 where agents are standing by to hear about your specific case.

Legal-Bay assists plaintiffs in all types of medical lawsuits, including medical malpractice, wrongful death, 3M cases, Hernia Mesh, IVC Filters, Roundup, Essure, personal injury, premise liability, judgement or verdict on appeal, appellate funding, commercial litigation, commercial case funding, portfolio loans, whistleblower advance and Qui-Tam funding, copyright infringement loans, patent infringement funding, and more.

All funding programs are risk-free as you only repay the advance if your case is successful. The non-recourse cash advance is not a lawsuit loan, lawsuit loans, pre settlement loan, loans for settlement, or pre-settlement loans.